Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide
Open Access
- 18 March 2002
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 69 (4) , 281-284
- https://doi.org/10.1002/ajh.10072
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyBritish Journal of Haematology, 2000
- Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcomaCancer, 1997
- Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemiaLeukemia Research, 1995
- Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptomsHepatology, 1994
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 1993
- DefibrotideDrugs, 1993
- Hepatic veno-occlusive diseaseThe American Journal of Medicine, 1986
- Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantationThe American Journal of Medicine, 1980
- Veno-Occlusive Disease of the Liver After Chemotherapy of Acute LeukemiaAnnals of Internal Medicine, 1976